Efficacy of N-Acetylcysteine (NAC) in Preventing COVID-19 From Progressing to Severe Disease

Clinical trial NCT04419025 · COMPLETED

Trial details

NCT number: NCT04419025
Sponsor: Cambridge Health Alliance
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

COVID Sars-CoV2 SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere Oxidative Stress

Start date: 2020-09-23
Primary completion: 2021-05-14
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.